Ulrich Sauerzopf
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Continuous infusion [11C]-(+)-PHNO PET for measuring dopamine D2/3 receptor availability and amphetamine effects across the brain: Feasibility and test-retest reliability.
Journal: European journal of nuclear medicine and molecular imaging
Published: February 06, 2026
Ketamine for negative and depressive symptoms in schizophrenia: the evidence so far.
Journal: Frontiers in psychiatry
Published: December 12, 2025
The relationship between prefrontal cortex gray matter volume and subcortical dopamine release - an addendum.
Journal: Molecular psychiatry
Published: September 05, 2023
Disrupted relationship between blood glucose and brain dopamine D2/3 receptor binding in patients with first-episode schizophrenia.
Journal: NeuroImage. Clinical
Published: May 07, 2021
Association of dopamine D2/3 receptor binding potential measured using PET and [11C]-(+)-PHNO with post-mortem DRD2/3 gene expression in the human brain.
Journal: NeuroImage
Published: May 05, 2020
On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D2/3 receptor agonist radioligand study.
Journal: Translational psychiatry
Published: September 02, 2019
Toward the Optimization of (+)-[11C]PHNO Synthesis: Time Reduction and Process Validation.
Journal: Contrast media & molecular imaging
Published: January 20, 2019
Making Sense of: Sensitization in Schizophrenia.
Journal: The international journal of neuropsychopharmacology
Published: July 12, 2016
Are reprogrammed cells a useful tool for studying dopamine dysfunction in psychotic disorders? A review of the current evidence.
Journal: The European journal of neuroscience
Published: June 22, 2016
In vitro growth of Plasmodium falciparum in neonatal blood.
Journal: Malaria journal
Published: August 10, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026